Warner pharmaceutical factory: The injection of metaproterenol sulfate has obtained the drug registration certificate.

Warner Pharmaceutical Factory announced on December 25th that the company has received the Drug Registration Certificate for the injection of metaraminol bitartrate approved and issued by the National Medical Products Administration. Metaraminol bitartrate injection is used for the restoration of blood pressure in cases of acute hypotension; it can also be used for the auxiliary treatment of cardiac arrest and to maintain blood pressure after cardiac arrest resuscitation.